Gluten Immunogenic Peptides (GIP) - ANVISA Registration 80464810900

Access comprehensive regulatory information for Gluten Immunogenic Peptides (GIP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810900 and manufactured by IMMUNDIAGNOSTIK AG. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.